BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31807855)

  • 1. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.
    Nozawa H; Sonoda H; Ishii H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Kawai K; Hata K; Ishihara S
    Int J Colorectal Dis; 2020 Jan; 35(1):177-180. PubMed ID: 31807855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
    Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M
    World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy improves prognosis of resectable stage IV colorectal cancer: a comparative study using inverse probability of treatment weighting.
    Nozawa H; Takiyama H; Hasegawa K; Kawai K; Hata K; Tanaka T; Nishikawa T; Sasaki K; Kaneko M; Murono K; Emoto S; Sonoda H; Nakajima J
    Ther Adv Med Oncol; 2019; 11():1758835919838960. PubMed ID: 31019569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
    Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
    Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal Cancer-Predictive Factors and Prognosis.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Kaneko M; Murono K
    Clin Colorectal Cancer; 2018 Mar; 17(1):e91-e97. PubMed ID: 29113730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
    Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri-operative chemotherapy for resectable colorectal lung metastasis: a systematic review and meta-analysis.
    Li Y; Qin Y
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):545-553. PubMed ID: 32036456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.
    Loree JM; Kennecke HF; Renouf DJ; Lim HJ; Vickers MM; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2016 Dec; 15(4):352-359.e1. PubMed ID: 27265355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis.
    Araujo RL; Gönen M; Herman P
    Ann Surg Oncol; 2015 Sep; 22(9):3070-8. PubMed ID: 25586244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: A multi-institutional retrospective study.
    Song JH; Kim SH; Lee JH; Cho HM; Kim DY; Kim TH; Kim SY; Baek JY; Oh JH; Nam TK; Yoon MS; Jeong JU; Kim K; Chie EK; Jang HS; Kim JS; Kim JH; Kang KM
    Radiother Oncol; 2016 Feb; 118(2):387-92. PubMed ID: 26763136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
    Pan Z; Peng J; Lin J; Chen G; Wu X; Lu Z; Deng Y; Zhao Y; Sui Q; Wan D
    Cancer Commun (Lond); 2018 May; 38(1):29. PubMed ID: 29843800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J; Thephamongkhol K
    BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study.
    He H; Zhang P; Li F; Liu D; Wu K
    J Gastrointest Oncol; 2022 Dec; 13(6):2736-2748. PubMed ID: 36636082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.
    Liang L; Zhu J; Jia H; Huang L; Li D; Li Q; Li X
    Oncotarget; 2016 Jan; 7(1):1014-28. PubMed ID: 26510910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.